1 - Research experience and ability
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
FP-MCRN - Family Pediatricians Medicines for Children Research Network |
| Number of completed trials | 1 |
| Number of ongoing trials | 1 |
| Total number of participants actually recruited each year | 1000 |
| Proportion of eligible participants actually recruited each year | 1800 |
| Describe way of screening and participant recruitment | The FP-MCRN can survey many Italian children.The merit of FP is their close elective involvement with children and their families. In Italy, a FP generally establishes a very strong and close “pediatrician-parents” and “pediatrician-child” relationship. For this reason it become easier the capacity to assess and involve outpatients in clinical trials. Practical reasons:1) Numbers of patients;2)FP as a member of the family;3) Direct relationship with the children;4) Presence of territorial pathologies;5) Frequency of the contacts out-patient both in ambulatory and domiciliary : Importance of the family communication. 1)Explain in simple way, easily comprehensible and with sincerity; 2)Reassurance on:importance of the benefits,risks minimisation; experience of the pediatricians; the policy privacy;the protection of the data;3)Correct information and family consent ;4) Correct Information and Children Assent |
| Total number of collaborating centres | 10 |
| Academic investigator initiated studies | |
| Number of ongoing and completed clinical trials. Absolute number | 2 |
| Number of ongoing and completed clinical trials. Proportion of all studies | REDS (Respiratory Drugs Survey) Study. Active Surveillance of Respiratory Drugs and in Particular of Inhaled Steroids (IS) in the Paediatric Age. International Journal of Pediatrics and Child Health, 2018, 6, 27-41 |
| Number of paediatric specialties covered by paediatric trials] | 2 |
| Number of paediatric conditions covered by paediatric trials] | 2 |
| Number of other ongoing research studies programs] | 0 |
| Proportion of academic initiated studies | 100% of the budget derived from governmental programs (AIFA PhVG Call ) |
| Proportion of budget | 100% of the budget derived from governmental programs (AIFA PhVG Call ) |
| Number of registered study participants. All studies |
0 |
| Number of ongoing and completed trials | 2 |
| Number of paediatric specialties covered by paediatric trials | 2 |
| Number of paediatric conditions covered by paediatric trialss | 2 |
| Number of registered study participants all studies | 0 |